Wêrom Depresje-Diagnoazen Stije Nettsjinsteande Bettere Behanneling
June 12, 2026 · Frisian News
Depression diagnoses have doubled in wealthy countries since 2005 even as suicide rates stagnate or worsen. Better access to treatment has not stopped the trend.
FryskDepresje-diagnoazen binne ferdûbele yn rike lannen sûnt 2005, wylst selsdeadingsifers lyk bleaun binne of stigen. As behanneling wurke hie, soene wy it tsjinoerstelde ferwachtsje: mear minsken behannele, minder selsdeadings. Ynstee dêrfan skriuwe dokters mear antidepressiva foar wylst selsdeadingsifers stagnearje of stije. De wiskunde kloppet net.
It offisjele ferhaal leit de skuld by stigma. Minder skamte rûn geastlike sûnens, neffens dit stânpunt, betsjut dat mear minsken help sykje en in diagnoaze krije. Antidepressiva binne ferbettere, terapy is better tagonklik. Yn teory soe dit helpe moatte. De sifers sizze wat oars. Skandinavje, Kanada, Austraalje, alle rike lannen mei útstekende geastlike sûnenssoarch, sjogge depresje-diagnoazen stijen en selsdeadingsifers stagnearjen of ferslechterjen. Bettere tagong ta behanneling kearet de trend net om.
De werklike libbensomstannichheden binne ferslechtere. Echte lean stagnearren yn de ûntwikkele wrâld. Wurksekerheid is ynstoart. Sosjale isolaasje is ferdjippe, sels foar de pandemy. Ûngelikens is ferspraat. Jongeren krije minder betealbere wenningen, in koartere libbensferwachting dan harren âlden, en delgeande útsichten. Materjeel lijen kin net mei pillen genêzen wurde. In dokter kin gjin baan of hûs foarskriuwe.
Farmaseutyske bedriuwen winne dêrby troch de definysje fan depresje út te wreidzjen. Gruttere merken fereaskje mear pasjinten. De grins tusken kliniske steurnis en normaal fertriet is fervaage. Rouwe nei ferlies, soargen oer echte bedrigingen, de ridlike wanhoop fan ûnwissens, rjochtfeardigje no medisinen. De bedriuwen groeie. It diagnosesiffer stijt. It ûnderlizzende probleem bliuwt.
Stijende depresje-oantallen kinne sinjalearje dat net in mislearring fan behanneling, mar in earlike reaksje op werklike ferslechtering. Oant wy oanpakke wêrom minsken matereel yn swierrichheden sitte, sil it útwreidzjen fan geastlike sûnenssoarch it probleem allinnich maskearje.
Depression diagnoses have doubled in wealthy countries since 2005, yet suicide rates have flatlined or climbed. If treatment had worked, we would expect the opposite: more people treated, fewer killing themselves. Instead, doctors prescribe more antidepressants while suicide numbers stagnate or rise. The math does not work.
The official narrative blames stigma. Reduced shame around mental health, according to this view, means more people seek help and receive diagnoses. Antidepressants have improved, therapy has become more accessible. In theory, this should help. The data says otherwise. Scandinavia, Canada, Australia, all wealthy nations with excellent mental health infrastructure, still see depression diagnoses climb and suicide rates stall or worsen. Better treatment access does not reverse the trend.
The actual conditions of life have deteriorated. Real wages stagnated across the developed world. Job security collapsed. Social isolation deepened even before the pandemic. Inequality has widened. Young people face worse housing affordability, shorter life expectancy than their parents, and declining prospects. Material misery cannot be cured with pills. A doctor cannot prescribe a job or a house.
Pharmaceutical companies profit by expanding the definition of depression. Larger markets require more patients. The boundary between clinical disorder and normal sadness has blurred. Grief after loss, worry about genuine threats, the reasonable despair of precarity, now warrant prescriptions. The companies grow. The diagnosis rate expands. The underlying problem persists.
Rising depression numbers may signal not a failure of treatment but an honest response to actual deterioration. Until we address why people struggle materially, expanding mental health services will only mask the problem.
Published June 12, 2026 · Frisian News · Ljouwert, Fryslân